Oncology

The survey also found that as the number of lumps seen increased, the likelihood of sampling decreased. Could a “wait-and-see” approach be costing dogs valuable treatment time and compromising outcomes?

The treatment’s success could have important implications for human cancer research.

The pioneering research was launched by the Humanimal Trust, a United Kingdom charity.

Learn more about cancer screening tests, including some of the latest ones, and more in this interview with Zachary Wright, DVM, DACVIM (Oncology).

From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist review, Vetscan Imagyst® AI Masses is designed to assist with challenging cases – giving teams added confidence at the point of care. In this video, Zoetis leaders highlight what these advances mean for the clinic, the pet owner, and the patient.

Cornell University Hospital for Animals has installed Varian's Edge linear accelerator and a Siemens Naeotom Alpha photon-counting CT scanner to improve outcomes

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors in dogs.

The funds will be used to support pet owners who cannot afford chemotherapy, surgery and other lifesaving treatment.

One of the biggest challenges is knowing when and where to refer a client.

Jeffrey N. Bryan, DVM, PhD, MS, DACVIM, discusses current methods and the need for advancement in how bone cancer is managed in dogs.

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum.

Frederick R. Appelbaum, MD, recognized for advancing marrow transplantation, talks about the impact of canine research on human and veterinary medicine.

Renowned American physician‑scientist Frederick R. Appelbaum, MD, discusses the development of bone marrow transplantation as a curative therapy at the 2025 ACVIM Forum.

Practical suggestions for veterinary professionals

Medicus Pharma submitted a product development plan to the FDA for an investigational new animal drug designation.

When patients come in the clinic, what red flags could general practitioners be on the look out for to indicate cancer?

Craig Clifford, DVM, MS, DACVIM (Oncology), and Christine Mullin, VMD, DACVIM (Oncology), discuss the logistics and implications of immunotherapy treatments for canine oncology patients.

Lola, a 9-year-old golden retriever, was referred to UC Davis William R. Pritchard Veterinary Medical Teaching Hospital after she was diagnosed with oral melanoma

Surgeons at Washington State University’s Veterinary Teaching Hospital removed a pheochromocytoma from a 12-year-old dog named Jessie

Natalie Marks, DVM, CVJ, CCFP, Elite FFC-V, reacts to the ability to utilize thermal imaging to detect mast cell tumors in dogs with high confidence.

OST-HER2 could be a frontline treatment for dogs and humans

Petco Love’s donations to the UC Davis School of Veterinary Medicine are helping patients like Diamond, a 12-year-old Pitbull terrier with hemangiosarcoma

A 9-year-old Catahoula mix presented to the veterinary clinic with a limp in his left front leg.

Benevet Oncology will adapt Privo Technologies’ platforms to advance cancer treatments for animals